# Department of Defense - Navy – FDA Inspection, Mar 4, 2026

Source: https://www.keypedia.com/records/fda_inspections/department-of-defense-navy/b762dab4-2625-4da0-b8ae-9ae8ddc35d97
Source feed: FDA_Inspections

> FDA inspection 1305570 of Department of Defense - Navy, March 04, 2026. 1 citation under 21 CFR part 630. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1305570
- Company Name: Department of Defense - Navy
- Inspection Date: 2026-03-04
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: San Francisco District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1204978 - 2023-04-20
- FDA Inspection 1093450 - 2019-05-16
- FDA Inspection 986414 - 2016-09-16
- FDA Inspection 841461 - 2013-06-28
- FDA Inspection 745751 - 2011-08-30

## Related Officers

- [FDA Personnel](https://www.keypedia.com/people/maurine-fadlalla/519e6e71-a50a-43b5-b41a-2249ec9afdd5)

Company: https://www.keypedia.com/companies/department-of-defense-navy/3d5371bb-4187-4b51-a51a-6c13f8806f47

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df